| Madison Stout, PT, DPT | |
|
3201 Sw Regency Pkwy, Bentonville, AR 72712-7469 | |
| (479) 252-3321 | |
| Not Available |
| Full Name | Madison Stout |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 3201 Sw Regency Pkwy, Bentonville, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861174575 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Fusion Therapy Center Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1801552435 PECOS PAC ID: 3173981776 Enrollment ID: O20230613003817 |
News Archive
Scandinavian cardiovascular diagnostics specialist CardiNor AS today announced two new studies have been published by the group at Akershus University Hospital led by Professor Torbjørn Omland and Associate Professor Helge Røsjø in leading journals that strongly support secretoneurin as a new, important biomarker for cardiovascular disease.
In an early step toward letting severely paralyzed people speak with their thoughts, University of Utah researchers translated brain signals into words using two grids of 16 microelectrodes implanted beneath the skull but atop the brain. "We have been able to decode spoken words using only signals from the brain with a device that has promise for long-term use in paralyzed patients who cannot now speak," says Bradley Greger, an assistant professor of bioengineering.
Pfizer and Pain Therapeutics, Inc. announced that a Complete Response Letter was received from the U.S. Food and Drug Administration (FDA) on the resubmission to the new drug application (NDA) for REMOXY® (oxycodone) Extended-Release Capsules CII. Pfizer is working to evaluate the issues described in the Complete Response Letter and plans to have further discussions with FDA around them.
Children given an injectable medication to help prevent severe respiratory illness had a 17.6 percent higher likelihood of receiving the American Academy of Pediatrics (AAP) recommended doses when they were administered through a specialty pharmacy rather than a traditional pharmacy, according to a new study released today by pharmacy benefit manager Prime Therapeutics (Prime).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Madison Stout, PT, DPT 3201 Sw Regency Pkwy, Bentonville, AR 72712-7469 Ph: () - | Madison Stout, PT, DPT 3201 Sw Regency Pkwy, Bentonville, AR 72712-7469 Ph: (479) 252-3321 |
News Archive
Scandinavian cardiovascular diagnostics specialist CardiNor AS today announced two new studies have been published by the group at Akershus University Hospital led by Professor Torbjørn Omland and Associate Professor Helge Røsjø in leading journals that strongly support secretoneurin as a new, important biomarker for cardiovascular disease.
In an early step toward letting severely paralyzed people speak with their thoughts, University of Utah researchers translated brain signals into words using two grids of 16 microelectrodes implanted beneath the skull but atop the brain. "We have been able to decode spoken words using only signals from the brain with a device that has promise for long-term use in paralyzed patients who cannot now speak," says Bradley Greger, an assistant professor of bioengineering.
Pfizer and Pain Therapeutics, Inc. announced that a Complete Response Letter was received from the U.S. Food and Drug Administration (FDA) on the resubmission to the new drug application (NDA) for REMOXY® (oxycodone) Extended-Release Capsules CII. Pfizer is working to evaluate the issues described in the Complete Response Letter and plans to have further discussions with FDA around them.
Children given an injectable medication to help prevent severe respiratory illness had a 17.6 percent higher likelihood of receiving the American Academy of Pediatrics (AAP) recommended doses when they were administered through a specialty pharmacy rather than a traditional pharmacy, according to a new study released today by pharmacy benefit manager Prime Therapeutics (Prime).
› Verified 3 days ago
Mrs. Heidi Marie Epperson, MS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Tiger Blvd., Bentonville, AR 72712 Phone: 479-254-5065 Fax: 479-271-1123 | |
Ms. Tiffany Pharr Currier, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 203 Se 22nd St, Suite 9, Bentonville, AR 72712 Phone: 479-273-9933 Fax: 479-273-9935 | |
Mrs. Leah Britt Dugal, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1601 Greenhouse Rd, Bentonville, AR 72713 Phone: 479-795-1260 | |
Chelsea Waldkirch, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1010 Nw J St Ste I, Bentonville, AR 72712 Phone: 479-440-4147 | |
Mr. Noel C. Tugwell, MPT, MS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1002 Westpark Dr, Ste 6, Bentonville, AR 72712 Phone: 479-250-4014 Fax: 479-250-4015 | |
Mr. David Logan Hill, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 908 Nw 8th Street, Bentonville, AR 72712 Phone: 479-273-1141 Fax: 479-273-3762 | |
Ashley Spencer, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3201 Sw Regency Pkwy Ste 5, Bentonville, AR 72712 Phone: 479-252-3321 Fax: 479-668-2257 |